Kung; Hsiang-Fu

Patent Applications and Registrations

Patent applications and USPTO patent grants for Kung; Hsiang-Fu.The latest application filed is for "chemical compounds and their use as therapeutic agent and means of quality assessment of herbal medicines".

Company Profile

0.10.13

Kung; Hsiang-Fu - Hong Kong CN
Kung; Hsiang-fu - New Territories HK
Kung, Hsiang-Fu - Pokfulam CN
Kung; Hsiang-Fu - Middletown MD
Kung; Hsiang-Fu - Verona NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Inhibition of SARS-associated coronavirus (SCoV) infection and replication by RNA interference Grant 7,429,656 - Kung , et al. September 30, 2	2008-09-30
Telomerase reverse transcriptase fragments and uses thereof Grant 7,294,708 - Huang , et al. November 13, 2	2007-11-13
Chemical Compounds And Their Use As Therapeutic Agent And Means Of Quality Assessment Of Herbal Medicines App 20070148268 - QIAO; Chun Feng ; et al.	2007-06-28
Adeno-associated virus-mediated survivin mutants and methods related thereto App 20070081978 - Tu; Shui Ping ; et al.	2007-04-12
Gene therapy of HBV infection via adeno-associated viral vector mediated long term expression of small hairpin RNA (shRNA) App 20070027099 - Lin; Marie C. ; et al.	2007-02-01
Inhibition of SARS-associated coronavirus (SCoV) infection and replication by RNA interference App 20060258611 - Kung; Hsiang-Fu ; et al.	2006-11-16
Inhibition of SARS-associated coronavirus (SCoV) infection and replication by RNA interference Grant 7,129,223 - Kung , et al. October 31, 2	2006-10-31
Anti-depression formulations App 20060147569 - Kung; Hsiang-fu ; et al.	2006-07-06
Inhibition of hepatitis B virus (HBV) replication by RNA interference Grant 7,067,249 - Kung , et al. June 27, 2	2006-06-27
Animal model for fetal alcohol syndrome and methods of treatment App 20060037085 - Peng; Ying ; et al.	2006-02-16
Method for inhibiting fibrogenesis by a mixture of natural peptides from porcine liver extract App 20050191363 - Yang, Mengsu ; et al.	2005-09-01
Inhibition of SARS-associated coronavirus (SCoV) infection and replication by RNA interference App 20050004063 - Kung, Hsiang-Fu ; et al.	2005-01-06
Inhibition of hepatitis B virus (HBV) replication by RNA interference App 20040235775 - Kung, Hsiang-Fu ; et al.	2004-11-25
Combined adeno-associated virus and adenovirus cocktail gene delivery system for high efficiency gene expression without eliciting immune response in immuno-competent subjects App 20040223953 - Kung, Hsiang-Fu ; et al.	2004-11-11
Adeno-associated virus mediated B7.1 vaccination synergizes with angiostatin to eradicate disseminated liver metastatic cancers App 20040156828 - Xu, Ruian ; et al.	2004-08-12
Assay for the detection and quantification of HBV cccDNA by real-time PCR App 20040058314 - He, Ming Liang ; et al.	2004-03-25
Telomerase reverse transcriptase fragments and uses thereof App 20030225027 - Huang, Jun Jian ; et al.	2003-12-04
Inhibition of human immunodeficiency virus-1 infectivity in human cells Grant 5,668,149 - Oroszlan , et al. September 16, 1	1997-09-16
Recombinant immune interferon having an intact carboxyl terminus Grant 5,593,667 - Kung , et al. January 14, 1	1997-01-14
Immune interferon Grant 5,278,286 - Kung , et al. January 11, 1	1994-01-11
Crystalline human leukocyte interferon Grant 4,672,108 - Kung , et al. June 9, 1	1987-06-09
Homogeneous immune interferon fragment Grant 4,604,284 - Kung , et al. August 5, 1	1986-08-05
Method for the extraction of immune interferon Grant 4,476,049 - Kung October 9, 1	1984-10-09

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.